Capricor Therapeutics

(NASDAQ) CAPR

Current Price$26.76

Market Cap$1.62B

Since IPO (2013)-33%

5 Year+592%

1 Year+103%

1 Month-22%

Capricor Therapeutics Financials at a Glance

Market Cap

$1.62B

Revenue (TTM)

$0.00

Net Income (TTM)

-$114.59M

EPS (TTM)

-$2.31

P/E Ratio

-12.08

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$26.76

Volume

14,316

Open

$27.60

Price

$26.76

Volume

14,316

Open

$27.60

Previous Close

$26.76

Daily Range

$26.61 - $27.79

52-Week Range

$4.30 - $40.37

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$26.76

Volume

14,316

Open

$27.60

Previous Close

$26.76

Daily Range

$26.61 - $27.79

52-Week Range

$4.30 - $40.37

Estimated Earnings Date

Aug 11, 2026

CAPR News

Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story

Seena HassounaMay 10, 2026

Here's Why This Biotechnology Skyrocketed by 439% in December

Lee SamahaJan 9, 2026

CAPR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Capricor Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

231

CEO

Linda Marbán, PhD

Website

www.capricor.com

Headquarters

San Diego, CA 92121, US

CAPR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-56%

Return on Capital

-41%

Return on Assets

-35%

Earnings Yield

-8.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.62B

Shares Outstanding

57.91M

Volume

14.32K

Avg. Volume

1.23M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$108.14M

EBITDA

-$108.14M

Operating Cash Flow

-$69.81M

Capital Expenditure

-$2.90M

Free Cash Flow

-$72.72M

Cash & ST Invst.

$318.13M

Total Debt

$20.94M

Capricor Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.62B

N/A

Market Cap/Employee

$10.12M

N/A

Employees

160

N/A

Net Income

-$33.94M

-39.2%

EBITDA

-$36.77M

-49.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$257.49M

+79.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$13.94M

+3322.6%

Short Term Debt

$7.18M

+752.7%

Return on Assets

-35.12%

N/A

Return on Invested Capital

-40.98%

N/A

Free Cash Flow

-$40.00M

-428.2%

Operating Cash Flow

-$29.25M

-354.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CABACabaletta Bio, Inc.

CABACabaletta Bio, Inc.$3.25-7.41%

ACHVAchieve Life Sciences, Inc.

ACHVAchieve Life Sciences, Inc.$5.13-3.02%

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$1.88-7.84%

VNDAVanda Pharmaceuticals Inc.

VNDAVanda Pharmaceuticals Inc.$6.03-3.52%

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$4.37-8.58%

EDITEditas Medicine, Inc.

EDITEditas Medicine, Inc.$2.71-9.36%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$6.37-9.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$205.10-0.06%

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

Questions About CAPR

What is the current price of Capricor Therapeutics?

Capricor Therapeutics is trading at $26.76 per share.

What is the 52-week range for Capricor Therapeutics?

Over the past 52 weeks, Capricor Therapeutics has traded between $4.30 and $40.37.

How much debt does Capricor Therapeutics have?

As of the most recent reporting period, Capricor Therapeutics reported total debt of $21.12M.

How much cash does Capricor Therapeutics have on hand?

Capricor Therapeutics reported $105.42M in cash and cash equivalents in its most recent financial results.

What is Capricor Therapeutics’s dividend yield?

Capricor Therapeutics does not currently have a dividend yield.

Capricor Therapeutics

Capricor Therapeutics Financials at a Glance

CAPR News

Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story

Here's Why This Biotechnology Skyrocketed by 439% in December

CAPR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Capricor Therapeutics

CAPR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Capricor Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CAPR

What is the current price of Capricor Therapeutics?

What is the 52-week range for Capricor Therapeutics?

How much debt does Capricor Therapeutics have?

How much cash does Capricor Therapeutics have on hand?

What is Capricor Therapeutics’s dividend yield?

Premium Investing Services